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A 92-kDa polypeptide present in rabbit and dog cardiac muscle was purified to homogeneity and some 
of its properties were investigated using biochemical and cytochemical approaches. The protein was found 
to be similar, if not identical to macrophage gelsolin; it cross-reacts immunologically with anti-rabbit 
macrophage gelsolin antibody, has a Ca’+ -sensitive shortening effect on the actin filaments as judged by 
the high shear viscometry and sedimentation experiments, and has a similar amino acid composition. In 
addition, immunoblot and SDS polyacrylamide gel analysis of cardiac muscle extracts obtained at high 
and low ionic strength showed that this protein is tightly bound to myofibrils, both in the absence and 
presence of Ca’+, in ventricular as well as in atria1 muscle cells. Indirect immunofluorescence microscopy 
revealed a striated gelsolin staining pattern analogous to that previously observed for the skeletal muscle 
gelsolin, suggesting that in the muscle cell this protein is sharing the same localisation as actin. Because 
of its severing and nucleating properties the gelsolin may play a major role in the organization, assembly 
and turnover of the thin filaments within the muscle cells. 
Cardiac muscle Gelsolin Myofibril 
1. INTRODUCTION 
Actin is a major and essential constituent of the 
contractile machinery of both muscle and non- 
muscle cells. It is constantly being reorganized in 
response to a wide variety of factors controlling 
the filament number, length and their interaction 
with each other and with other cellular structures. 
In addition to the ionic conditions, actin filament 
assembly in vivo may be affected by numerous 
actin-binding proteins believed to be involved in 
maintaining cell architecture and generating move- 
ment. Although the mechanism of these interac- 
tions is not yet well known, such proteins include 
a category whose activities are regulated by 
changes in Ca2+ concentration [l-5]. 
One of these proteins is gelsolin, a 
Ca*+-dependent regulatory protein of actin gel-sol 
transformation, first discovered and purified from 
rabbit lung macrophages [6,7]. Gelsolin acts rever- 
* To whom correspondence should be addressed 
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sibly by shortening the average length of actin 
filaments at steady state in the presence of 
micromolar concentrations of calcium. It also in- 
fluences both the nucleation and elongation steps 
of actin assembly by blocking the barbed end 
[8-l 11. Recently, using the gelsolin antiserum, it 
has been demonstrated, by an indirect im- 
munohistochemical technique, that gelsolin is pre- 
sent in substantial amounts not only in non-muscle 
cells and tissues, but also in smooth, skeletal and 
cardiac muscles [ 121. This last finding is unex- 
pected and raises the question of great interest 
about how gelsolin may be involved in the function 
of the muscle where the actin molecules are 
assembled into thin filaments which are stable 
structures arranged in a highly organized manner 
especially in the sarcomeric muscles. Since 
Ca*+-sensitive actin assembly mechanism has been 
investigated only in non-muscle cells, we have been 
interested in studying the occurrence of such reac- 
tions in striated muscle cells. We report here the 
purification, preliminary biochemical character- 
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ization and cytochemical ocalisation of rabbit car- 
diac muscle gelsolin. 
2. MATERIALS AND METHODS 
Muscle gelsolin was isolated as follows: 100 g of 
rabbit heart previously perfused and washed 
several times in ice-cold 0.08 M NaCl solution was 
either frozen until use or homogenized in 5 vols of 
0.3 M KCl, 0.2 mM ATP, 0.5 mM MgC12,0.5 mM 
dithiothreitol, 50 mM imidazole-HCl (pH 7.2), 5 
mM EGTA, 0.1 mM NaN3. Antiproteases such as 
phenylmethylsulfonylfluoride (0.1 mM), trypsin 
inhibitor (10 fig/ml) and cu-macroglobulin (10 
/g/ml) were added before blending for twice 30 s 
at 4°C. After standing for 30 min, the mixture was 
centrifuged at 100000 x g for 60 min. The super- 
natant was then filtered carefully through two 
layers of gauze and fractionated with solid am- 
monium sulfate. The pellet resulting from 20% 
saturation was discarded and the supernatant 
made up to 50% saturation. The harvested am- 
monium sulfate pellet was dissolved in a buffer 
consisting of 20 mM Tris-HCl (pH 7.8), 5 mM 
EGTA, 1 mM dithiothreitol, 0.1 mM NaN3, 0.1 
mM PMSF and 10% glycerol and dialyzed over- 
night against the same buffer. Insoluble materials 
were removed at 100000 x g for 60 min and the 
clear supernatant was applied to a (2.5 x 20 cm) 
column of DEAE-Sepharose CLdB (Pharmacia) 
equilibrated in the same buffer and eluted with a 
linear O-O.6 M KC1 gradient. Gelsolin-containing 
fractions were pooled, dialyzed against 0.8 M KCl, 
1 mM DTT, 1 mM EGTA, 10 mM Tris-HCl (pH 
7.5), concentrated to 5 ml by ultrafiltration 
through an Amicon PM 30 and applied to a 1.5 x 
150 cm column of Sephadex G-150 equilibrated 
and eluted with the same buffer. The eluate was 
analyzed by 5-15070 polyacrylamide gel electro- 
phoresis in the presence of 0.1% SDS (SDS- 
PAGE) using the discontinuous buffer system in 
[13] and was checked for its ability to decrease the 
viscosity of F-actin solutions. Gelsolin-containing 
fractions were combined, concentrated, dialyzed 
against 50 mM potassium phosphate (pH 7.5) and 
applied to a column of hydroxyapatite (1.5 x 12 
cm). The column was first washed with 100 ml of 
100 mM potassium phosphate, and then eluted 
with a linear gradient of 0.1-l M phosphate buf- 
fer, pH 7.5 (2 x 100 ml). Fractions containing the 
92-kDa protein and emerging at approximately 
0.15 M phosphate were pooled and identified as 
pure gelsolin by SDS-PAGE. These fractions were 
either stored at - 3O’C in 40% glycerol (v/v) or 
dropped in liquid nitrogen to form frozen protein 
balls and stored at -70°C until use. 
Macrophage gelsolin was prepared from rabbits 
as in [7]. 
Serum gelsolin was purified from healthy human 
serum as indicated for muscle gelsolin except that 
in the starting step the collected serum was directly 
cut by crystallized ammonium sulfate (30-50% 
saturation). 
Actin was isolated from acetone powder of rab- 
bit skeletal muscle as in [ 141. 
Protein concentrations were obtained using EfE 
at 290 nm of 6.3 for G-actin and of 6.6 for F-actin 
[ 151. Gelsolin concentration was assayed as in [ 161 
and [ 171, using crystalline bovine serum albumin as 
standard. 
Amino acid analysis was performed on a 
Beckman model 120 C autoanalyzer using a single 
column. For this purpose, samples of purified car- 
diac muscle gelsolin were dialyzed extensively 
against distilled water, lyophilized and hydrolyzed 
with 6 M HCl at 105°C for 48 h in an evacuated, 
sealed tube. 
Myofibril preparation was essentially as in [18]. 
Viscosity was measured at 25°C by a Cannon- 
Manning semimicroviscosimeter (extra low charge, 
size 100) with a charge volume of 0.25 ml. A ther- 
mostatted rolling ball viscometer was also used to 
detect active fractions after each purification step 
t191. 
Immunological experiments: antibodies to rab- 
bit cardiac muscle gelsolin were obtained by im- 
munisation of goat with rabbit alveolar 
macrophage gelsolin which was further purified by 
SDS-PAGE. Immunoglobulins IgG from immune 
serum precipitated by ammonium sulfate (50070 
saturation). In some cases, analytical quantities of 
specific antibodies to gelsolin were purified using 
nitrocellulose paper as in [20]. Thin frozen sections 
(0.1-0.2 pm) of rabbit atria1 and ventricular car- 
diac muscle were obtained as in [21]; small pieces 
of tissue were fixed in 2% formaldehyde, infused 
in 1.2 M sucrose and frozen in liquid nitrogen. 
Thin sections were then obtained with a Reichert 
Ultrocut microtome with a FE4 cryoattachment 
and treated for immunofluorescence staining; they 
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were first incubated for 30 min in purified an- 
tibodies against gelsolin at 60pg/ml in phosphate 
buffered saline (PBS) with 3% bovine serum 
albumin and 3% calf serum. After thorough 
washing in the buffer, specimens were stained 30 
min in rhodamine-conjugated rabbit antigoat IgG 
(50 fig/ml in PBS) prepared as in [22]. Sections 
were examined with a Zeiss epifluorescence 
microscope equipped with interferential filters and 
with Planapochromat objectives 40 x and 63 x . 
Photographs were taken on Kodak Tri X films. 
Controls were made by omitting the first specific 
antibody. 
3. RESULTS AND DISCUSSION 
3.1. Isolation of cardiac gelsolin and its 
association with myofibrils 
The present investigation demonstrates that rab- 
bit cardiac muscle contains significant amounts of 
a 92-kDa actin-severing protein which was isolated 
in a pure state by ammonium sulfate fractionation 
and chromatography on DEAE-Sepharose, 
Sephadex G-150 and hydroxyapatite. The de- 
veloped procedure for purification of gelsolin has 
the advantage of being a simple, generated method 
for isolation of gelsolin-like proteins from muscle 
and non-muscle cells. Fig. 1 illustrates each of 
these purification steps. The final fraction (fig. 1, 
lane D) shows homogeneity of over 95% as esti- 
mated from a densitometric scan. The yield of the 
protein was about 5 mg from 100 g of heart 
muscle. 
The cardiac muscle protein was proved to be 
similar to alveolar macrophage gelsolin [7] and 
human serum gelsolin [23] in its molecular and 
biochemical properties. Its amino acid composi- 
tion, depicted in table 1, shows a great similarity 
with that of some other severing proteins. Using 
the immune replica technique, we found that the 
anti-serum to macrophage gelsolin specifically 
recognized the protein band with a relative mass of 
92 kDa present in the high-speed supernatant of 
extracts from the atria (fig.ZB) as well from the 
ventricles (fig.2C). The replica of purified cardiac 
gelsolin (fig.2D) comigrated with the band cor- 
responding to gelsolin in macrophage extract 
(fig.2A) slightly ahead of the replica of pure 
human serum gelsolin (fig.2E). The weakness of 




Fig. 1. SDS-PAGE (7.5%) of fractions obtained 
through the preparation of cardiac muscle gelsolin. Lane 
(A) represents M, markers (from top to bottom): M, 
myosin heavy chain, 200 kDa; P, phosphorylase b, 94 
kDa; B, serum albumin, 68 kDa; A, actin, 43 kDa. Lane 
(B) contains pooled fractions with actin-modulating pro- 
tein eluted from the DEAE-Sepharose column. Lane (C) 
contained pooled fractions with actin modulating pro- 
tein eluted from the Sephadex G-150 column. Purified 
cardiac gelsolin eluted from the hydroxyapatite column 
is shown in lane (D). 
cardiac muscle extracts prepared at a moderate 
ionic strength (60 mM KCI) (fig.2B,C) led us to 
further investigate by SDS-PAGE and immune 
replica, the possible association of the protein with 
myofibrils. The analysis of supernatants and 
pellets issued from cardiac muscle extracted at dif- 
ferent salt concentrations (0. l-l M KCI) revealed 
that the cardiac gelsolin was not a readily soluble 
fraction component. Its solubility from myofibrils 
was a function of salt concentration but indepen- 
dent of Ca’+/EGTA ratios since up to 90% of the 
intensity of the immunoreaction was found in car- 
diac myofibrils (fig.3A,B) and since the same pat- 
tern was found in the presence of Ca’+ or EGTA. 
Fig.3C,D and fig.3F,G represent he supernatants 
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Table 1 
Amino acid composition of cardiac muscle gelsolin and 















Asx 10.1 10.5 9.5 
Thr 5.2 5.2 5.6 
Ser 7.7 6.4 6.8 
GlX 12.5 12.8 11.8 
Pro 5.2 6.8 6.8 
ClY 7.5 8.9 8.1 
Val 6.9 7.2 6.9 
Met 1.7 1.9 1.6 
Ileu 3.3 3.5 4.1 
Leu 7.2 9.2 8.1 
Tyr 2.9 3.1 2.7 
Phe 4.5 4.3 4.1 
Lys 5.8 5.8 6.0 
His 4.1 9.2 3.3 
Arg 5.5 5.5 5.2 
The analysis of cardiac gelsolin is compared to: 
a Human serum gelsolin prepared as described in the text 
b Rabbit lung macrophage gelsolin as in [7] 
and their immune replica obtained when the rabbit 
cardiac muscle was extracted in the presence of 0.1 
M and 0.6 M KCl, respectively. At 50-100 mM 
KCl, most of the gelsolin remained tightly 
associated with the insoluble myofibrillar fraction 
containing the bulk of the actin, myosin, 
tropomyosin and troponins (fig.3A,B). This find- 
ing was strongly suggestive of the presence of 
gelsolin in cardiac muscle as an integral part of the 
myofibril. In this context, it was demonstrated that 
in muscle cells, glycolytic enzymes, tropomyosin- 
troponin complex [25] and myosin light chain 
kinase [26] are tightly associated to filamentous ac- 
tin at ionic strengths comparable to, or higher 
than, those found in vivo. As shown in fig.4, car- 
diac gelsolin was found to reduce greatly the 
steady-state viscosity of preformed F-actin 
filaments increasing the critical concentration for 
actin assembly in presence of PM Ca2+ and con- 
trolling filament lengths similarly to macrophage 
gelsolin [8,9], actin depolymerizing factor [23] 
microvilli villin [28] and physarum fragmin [29]. A 
mixture of cardiac gelsolin and actin was prepared 
at a 1:50 molar ratio, and the effect on viscometry 
occurred either when the gelsolin was added after 
Fig. 2. Immunoblot analysis of macrophage, cardiac and serum gelsolin. The Coomassie blue-stained gel is shown on 
the left and the corresponding immunohistochemically stained gel replica of each sample on the right. (A) Homogenate 
of rabbit alveolar macrophages; (B) extract of rabbit atria1 cardiac muscle; (C) extract of rabbit ventricular cardiac 
muscle. Soluble extracts of A, B and C were prepared as in 1121. (D) pure cardiac muscle gelsolin; (E) pure human serum 
gelsolin; lanes (F) and (G) represent, respectively, a-actinin and a mixture of myosin heavy chain (M), phosphorylase 
b (P) and actin (A) as markers. 
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Fig. 3. Ionic strength-dependent solubilization of myo- 
fibrillar gelsolin. Cardiac muscle was extracted with 40 
mM borate, 0.5 mM MgC12, 0.5 mM DTT, 5 mM 
EGTA, 10 mM NaN3, 10 mM PMSF (pH 7.2) contain- 
ing 0.1 M or 0.6 M KC1 and centrifuged. The resulting 
pellet (lanes A,E) and supernatants (lanes C,F) were 
electrophoresed. Cross-reactivity with anti-gelsolin anti- 
body was performed on myofibrils (lane B) and on 
supernatants (lanes D and G). Note the solubilization of
cardiac gelsolin and its recovery in the supernatant. 
polymerization was achieved or when it was pre- 
sent during the course of the actin assembly. The 
elimination of the lag phase could be interpreted 
by the fact that gelsolin binds to monomeric actin 
and stimulates nucleus formation. 
3.2. Cytochemical localization of gelsolin in 
‘cardiac muscle 
To localize gelsolin in rabbit cardiac muscle, 
thin frozen sections were studied by indirect im- 
munofluorescent labelling, using purified anti- 
bodies elicited against alveolar macrophage 
gelsolin. The analysis of the cellular patterns clear- 
ly demonstrates that gelsolin was present in ven- 
tricular (fig.5a,b) and atria1 (fig.%) cardiac mus- 
cle. As shown for the latissimus dorsi muscle [12], 
the antibody binds specifically to gelsolin in the 
myofibrillar bands of myocardium. The immuno- 
reaction was more intense in the ventricular than in 
the atria1 myocardium. Gelsolin was also located in 
subsarcolemmal sarcoplasm, forming a regular 
underlining of the cardiomyocytes. In contrast, 
0 10 20 30 40 50 60 
TIME (men) 
Fig. 4. Time course of the effect of purified cardiac 
gelsolin on the viscosity of actin in the presence of cal- 
cium. Polymerization of G-actin (0.7 mg/ml in 2 mM 
Tris, 0.2 mM ATP, 0.1 mM CaClz and 0.2 mM 2-mer- 
captoethanol, pH 8.0) was initiated by the addition of 
KC1 to 0.1 M and MgC12 to 2 mM final concentration 
(o--o) and monitored by viscometry. After a steady- 
state viscosity was reached, cardiac gelsolin was added to 
preformed F-actin at a final molar ratio of 1:SO. Note 
the rapid drop in viscosity (O--O) after addition of 
gelsolin at the time indicated by the arrow. In a parallel 
sample (A-4), cardiac gelsolin was mixed with G-actin 
in the same buffer, 15 min before adding salt to induce 
actin polymerization. 
contact regions (intercalated discs) as well as 
nucleus and internal sarcoplasm were always 
negative. Some cardiomycytes appeared brighter 
especially in the ventricle. The cardiac vessel 
smooth muscle also exhibited a strongly positive 
reaction in this immunostaining. This is in agree- 
ment with the recent observation [12] suggesting 
that smooth muscles have a very high gelsolin con- 
tent. Finally this specific localization of gelsolin 
was not found in the control, where the specific 
gelsolin antibody was omitted (not shown). 
Intracellularly, the gelsolin was suggested to 
solvate actin gels in the presence of Ca2+ > lo- 6 
M and may thus regulate the consistency of cyto- 
plasm [9], whereas the major role of the serum 
gelsolin may be in clotting or in clearing actin 
filaments from the circulation as a consequence of 
tissue damage or turnover [23,24]. Possible identi- 
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Fig. 5. Indirect immunofluorescence staining of myocardium using anti-gelsolin antibody. Longitudinal sections of rab- 
bit ventricular (Sa,b) and atria1 (5~) cardiac muscle cells demonstrate an periodically distributed reaction (v). Moreover, 
the subsarcolemmal cytoplasm (d) appears clearly stained whereas the nucleus (n) was always negative. Vessel 
smooth muscle (v) appears trongly fluorescent. Some heterogeneity of the immuno-reaction is observed in neighbouring 
muscle cells (*). Bar, 25 pm. (5a) x 720, (5b,c) x 900. 
ty between these two intra- and extracellular actin- 
severing proteins was already suggested [12] and 
the action of tropomyosin in protecting F-actin 
from severing by macrophage gelsolin was also 
recently reported [30]. At present, we have no 
knowledge of the physiological function of gelsolin 
in cardiac or skeletal muscle. The data described 
here show that cardiac gelsolin which is physically 
and immunologically similar to non-muscle gel- 
solin seemed to form quite a tight complex with the 
myofibrils in vivo and in vitro and thus could con- 
tribute to the stability of the polymeric structures 
of the sarcomere. The gelsolin which presumably 
binds to F-actin in the presence of the regulatory 
proteins, could be involved essentially in the 
nucleation step of G-actin in situ and possibly in 
the turnover of the thin filaments within the 
myofibrils. 
In this context, it will be of great interest to 
know if muscle gelsolin has such an important role 
during the physiological processes of moulting, 
and/or during pathological phenomena of dam- 
aged tissue or cellular injury such as myocardial in- 
farctus and coronary occlusion. Studies are cur- 
rently underway to examine the precise localization 
of the gelsolin within the myofibril itself and the 
possible role of this protein in myofibril assembly 
in striated muscle. 
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